Hebei Senlang Biotechnology Co., Ltd.
PrivateLast Round
Early Funding
May 18, 2022
Total Funding Raised
$29.6M
Company Overview
Hebei Senlang Biotechnology Co., Ltd. is a biotechnology company that develops tumor cell immunotherapy products, including CAR-T and other cell therapy platforms for the treatment of hematological and lymphoid malignancies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hebei Senlang Biotechnology Co., Ltd. Comparables
Compare Hebei Senlang Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bioceltech Therapeutics, Ltd. | 39% | |
| Shanghai Unicar-Therapy Bio-medicine Technology | 35% | |
| Shanghai YaKe Biotechnology | 33% | |
Hebei Senlang Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | May 18, 2022 |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2022
Raised $30M in early funding.
Hebei Senlang Biotechnology Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hebei Senlang Biotechnology Co., Ltd.'s valuation, stock price, and market status.